SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-013537
Filing Date
2023-04-25
Accepted
2023-04-25 16:52:12
Documents
3
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 formdef-14a.htm DEF 14A 654115
2 proxy_001.jpg GRAPHIC 290581
3 proxy_002.jpg GRAPHIC 92711
  Complete submission text file 0001493152-23-013537.txt   1183261
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41159 | Film No.: 23845598
SIC: 2834 Pharmaceutical Preparations